Stockreport

Cancer Genetics, Inc. Changes The Paradigm For Lung Cancer Monitoring – Launches Clinically Actionable, Multi-Gene, Liquid Biopsy Test For Lung Cancer Patients, Liquid::Lung-cfDNA™

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
PDF CGI has launched the multi-gene, next-generation sequencing (NGS) panel with CLIA validation, and will perform the test for both clinical care and for trials being perfo [Read more]